MIRM Stock Analysis: Buy, Sell, or Hold?
MIRM - Mirum Pharmaceuticals, Inc. Common Stock
$103.22
0.30 (0.29%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When MIRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MIRM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MIRM is 9.6% above fair value ($94.21). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MIRM is 9.6% above fair value ($94.21). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MIRM is currently trading at $103.22, which is considered extended relative to its 30-day fair value range of $78.93 to $94.21. From a valuation perspective, the stock is trading at a discount (Forward PE: -582.5) compared to its historical average (181.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is approaching resistance at $103.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MIRM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is approaching resistance at $103.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MIRM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$78.93 -
$94.21
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
MIRM is technically overbought (RSI 81). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.6% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($109.90)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fair Price Analysis
30-Day Fair Range
$78.93 -
$94.21
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$89.47
Resistance Level
$103.81
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-582.46
Wall Street Target
$109.90
(+6.8%)
Revenue Growth (YoY)
47.2%
Profit Margin
-8.8%
PE vs Historical
-582.5 vs 181.2
CHEAP
Last updated: January 31, 2026 2:30 AM ET
Data refreshes hourly during market hours. Next update: 3:30 AM
Data refreshes hourly during market hours. Next update: 3:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Bjerkholt
SELL
9578 shares
2025-09-12
Laura Brege
SELL
17000 shares
2025-09-11
Christopher Peetz
SELL
40000 shares
2025-08-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced MIRM Option Strategies
Professional options setups generated by AI based on today's MIRM price and gamma walls.
